牛颈动脉异种移植血管用于血液透析通路
该回顾性研究分析了126例患者共134条牛颈动脉(BCA)移植物用于上肢血液透析通路的结局。1年一期通畅率32%,一期辅助通畅率49%,二期通畅率78%。感染需切除移植物者占7%。BCA移植物可作为ePTFE的替代选择,但需更大样本对照研究验证。
要点
- BCA移植物1年一期通畅率32%,一期辅助通畅率49%,二期通畅率78%。
- 感染需切除移植物者7%,发生于植入后1–9个月。
核心结论
- BCA移植物是ePTFE用于血液透析通路的满意替代选择。
- 本系列一期通畅率低于小型随机研究报道,但一期辅助与二期通畅率相似。
- 感染率似低于文献报道的ePTFE感染率。
- 需更大规模对照研究确认既往报道的优越一期通畅率是否可重复。
研究设计与样本
- 回顾性研究,2012年1月至2015年5月期间126例患者上肢植入134条BCA移植物(Artegraft)。
- 患者平均既往通路手术次数为1.8次。
- 采用Kaplan-Meier法计算一期、一期辅助和二期通畅率,log-rank法比较通畅率差异。
- 记录纵向感染风险。
主要发现
- 全组1年一期通畅率32%,一期辅助通畅率49%,二期通畅率78%。
关键数值与推荐
- 1年一期通畅率32%,一期辅助通畅率49%,二期通畅率78%。
临床怎么用
- BCA移植物可作为血液透析通路的ePTFE替代选择。
- 首次通路患者可能获得更优的一期及一期辅助通畅率。
- 需关注植入后1–9个月的移植物感染风险。
- 性别和肥胖状态不应作为选择BCA移植物的排除因素。
局限性
- 回顾性研究设计。
- 样本量有限(134条移植物)。
- 缺乏与ePTFE的直接对照。
- 需更大规模对照研究验证通畅率优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Bovine carotid artery (BCA) grafts have been described as a possibly superior alternative to expanded polytetrafluoroethylene hemoaccess grafts. However, published experience remains limited, and patency rates for nonautogenous arteriovenous grafts remain unsatisfactory. We report herein the largest published experience with the current generation of BCA grafts for dialysis access and analyze subgroups to determine whether obesity, gender, or prior access surgery influences patency. METHODS: We retrospectively reviewed 134 BCA grafts (Artegraft, North Brunswick, NJ) implanted for hemodialysis access in the upper extremities of 126 patients between January 2012 and May 2015. Patients had a mean of 1.8 prior access operations. Primary, primary assisted, and secondary patency rates were calculated using the Kaplan-Meier method, and longitudinal infection risk was tabulated. Patency differences were calculated using the log-rank method. RESULTS: For the entire group, 1-year primary patency was 32%, primary assisted patency was 49%, and secondary patency was 78%. Ten of 133 grafts (7%) developed infection requiring graft excision between 1 and 9 months after implantation. There was no statistical difference between men and women in primary or secondary patency (P = .88, P = .69). There was no difference in primary patency or secondary patency for patients with body mass index >30 or <30 (P = .85, P = .54). Patients who had a BCA graft as their first access attempt had a higher primary and primary assisted patency than that of patients who had the graft placed after prior access failure (P = .039, P = .024). CONCLUSIONS: This represents the largest published series of BCA grafts for arteriovenous grafts in the modern era. The primary patency of BCA grafts in this series was lower than that reported in a smaller randomized study. However, primary assisted and secondary patency were similar. Infection rates in this series appear to be somewhat lower than polytetrafluoroethylene infection rates reported in the literature. BCA grafts are a satisfactory alternative to expanded polytetrafluoroethylene for hemodialysis access, but larger controlled studies are needed to determine whether superior primary patency previously reported is a reproducible finding.
引用
- Pineda DM, Dougherty MJ, Wismer MC, et al. Bovine carotid artery xenografts for hemodialysis access. J Vasc Surg. 2017. PMID: 28366301. doi:10.1016/j.jvs.2016.12.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。